Vasomotor Rhinitis Persisting After Topical Antihistamine (Azelastine): What to Do Next

When a patient with vasomotor rhinitis continues to experience rhinorrhea, sneezing, postnasal drip, and nasal congestion despite an initial course of intranasal azelastine, a defined next-line protocol applies. This page outlines the clinical context and points to the complete structured regimen.

Clinical scenario

The patient presents with all four predominant symptom domains of vasomotor rhinitis:

Rhinorrhea Sneezing Postnasal drip Nasal congestion

Previous treatment — insufficient response

The prior step — topical antihistamine (azelastine) administered intranasally — did not achieve the expected improvement in rhinorrhea, sneezing, postnasal drip, and nasal congestion. Non-achievement of those goals is the trigger for escalation to this next-line protocol.

Next-line approach (partial overview)

The protocol directs attention to a different class of topical agent that has not yet been tried. Which specific agent and in what order is detailed in the complete evidence-based regimen.

Instant Access to Structured Evidence-Based Regimens

References

If the patient presents with the full range of symptoms including rhinorrhea with sneezing, postnasal drip, and congestion, a topical antihistamine may be initiated.

Consider topical agent not yet tried: antihistamine, corticosteroid, anticholinergic, or cromoglycate.

View source ↗